数据显示，共同药业5日均线为23.35元，10日均线为23.63元，5日均线较10日均线距离为-1.16%，呈现 均线死叉形态。该股最新价较10日均线乖离率为-2.56%。 资金流向方面，共同药业当日主力资金净流出106.29万元，占流通市值的0.06%。近五个交易日累计净 流出4117.22万元，占流通市值的2.33%。 风险提示：股市有风险，投资需谨慎。 截至2025年8月26日收盘，共同药业股价报23.02元，较前一交易日下跌1.29%。盘中最高触及23.37元， 最低下探至22.98元，成交量为38546手，成交金额为0.89亿元。 共同药业属于化学制药行业，公司主营业务为甾体药物原料的研发、生产及销售。公司产品主要包括性 激素、孕激素等甾体药物原料，下游应用领域涵盖医药制剂、保健品等行业。 ...

Group 1 - The core viewpoint of the news is that Hubei Gongtong Pharmaceutical Co., Ltd. has shown a decline in net profit despite an increase in total revenue, indicating potential challenges in profitability [1] - As of August 12, 2025, the company's stock price closed at 23.5 yuan, down 2.89%, with a trading volume of 81,400 hands and a transaction amount of 193 million yuan [1] - The latest quarterly report shows total revenue of 139 million yuan, a year-on-year increase of 13.90%, while net profit attributable to shareholders decreased by 69.50% to 1.08 million yuan [1] Group 2 - The company has a current ratio of 1.055, a quick ratio of 0.531, and a debt-to-asset ratio of 65.26%, indicating its liquidity and financial leverage [1] - Hubei Gongtong Pharmaceutical has made investments in 7 companies and participated in 15 bidding projects, showcasing its active engagement in the market [2] - The company holds 5 trademark registrations and 59 patents, along with 293 administrative licenses, reflecting its commitment to intellectual property and regulatory compliance [2]

New Stock Listings - Tianfu Long (603406) issued at a price of 23.60[1] - Youli Intelligent (920007) issued at a price of 23.99[1] Rights Issues and Announcements - China Heavy Industry (601989) cash option declaration period from August 13, 2025[1] - China Shipbuilding (600150) acquisition request period from August 13 to August 15, 2025[1] - Shenkai Co., Ltd. (002633) offer declaration period from July 29 to August 27, 2025[1] - ST Kelly (300326) offer period from July 17 to August 15, 2025[1] - Fushun Special Steel (600399) offer period from August 12 to September 10, 2025[1] Abnormal Fluctuations - Multiple stocks reported abnormal fluctuations, including *ST Yushun (002289) and Changcheng Military Industry (601606)[2][3] - Notable fluctuations also reported for companies like Li De Man (300289) and Dongjie Intelligent (300486)[3]

| 证券代码：300966 | 证券简称：共同药业 | 公告编号：2025-043 | | --- | --- | --- | | 转债代码：123171 | 转债简称：共同转债 | | 湖北共同药业股份有限公司 关于全资子公司购买资产暨关联交易的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、关联交易概述 湖北共同药业股份有限公司（以下简称"共同药业"或"公司"）全资子公司湖 北共同生物科技有限公司（以下简称"共同生物"）拟向湖北源科生物医药科技有限 公司（以下简称"源科生物"，系公司实际控制人控制下的另一企业）购买生产经营 所需的土地及地上附着物，用于新建 3000t/d 污水处理装置项目和甲类车间及配套设 施生产建设项目，交易各方履行审批程序后，将签署转让协议，转让价格合计不超 过 1,657.03 万元，本次交易资金来源为共同生物自筹资金。 公司于 2025 年 8 月 5 日召开了第三届董事会第七次会议、第三届监事会第六次 会议，审议通过了《关于全资子公司购买资产暨关联交易的议案》，其中关联董事系 祖斌对本议案回避表决。该议案已经公司独立董 ...

| 证券代码：300966 | 证券简称：共同药业 | 公告编号：2025-042 | | --- | --- | --- | | 转债代码：123171 | 转债简称：共同转债 | | 湖北共同药业股份有限公司 第三届监事会第六次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 具体内容详见公司同日在巨潮资讯网（www.cninfo.com.cn）披露的《关于全资 子公司购买资产暨关联交易的公告》（公告编号：2025-043）。 表决结果：同意 3 票，反对 0 票，弃权 0 票。本议案获得通过。 三、备查文件 1 第三届监事会第六次会议决议。 湖北共同药业股份有限公司（以下简称"公司"）第三届监事会第六次会议于 2025 年 8 月 5 日在公司会议室以现场结合通讯表决的方式召开。会议通知及材料于 2025 年 7 月 25 日以电话、微信等通讯的方式送达。会议由公司监事会主席蒋建军主 持，会议应到监事 3 人，实际参会监事 3 人。 会议的召开符合《中华人民共和国公司法》《湖北共同药业股份有限公司章程》 《湖北共同药业 ...

| 证券代码：300966 | 证券简称：共同药业 | 公告编号：2025-041 | | --- | --- | --- | | 转债代码：123171 | 转债简称：共同转债 | | 湖北共同药业股份有限公司 第三届董事会第七次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 湖北共同药业股份有限公司（以下简称"公司"）第三届董事会第七次会议于 2025 年 8 月 5 日在公司会议室以现场结合通讯表决的方式召开。会议通知及材料于 2025 年 7 月 25 日以电话、微信等通讯方式送达。会议由公司董事长系祖斌主持，会 议应到董事 7 人，实际参会董事 7 人，独立董事龙子午、祁飞、何德良以通讯表决 方式出席会议。公司高级管理人员列席了本次会议。 本议案在提交公司董事会审议前已经公司独立董事专门会议审议通过。 具体内容详见公司同日在巨潮资讯网（www.cninfo.com.cn）披露的《关于全资 子公司购买资产暨关联交易的公告》（公告编号：2025-043）。 关联董事系祖斌回避表决，其余 6 名董事参与了表决。 本次会 ...

Group 1 - The assisted reproductive concept sector declined by 1.60%, ranking among the top declines in concept sectors, with leading decliners including Lide Man, Hanyu Pharmaceutical, and Gongtong Pharmaceutical [1] - Among the 14 stocks that increased in price, Hc Pharma, Madi Technology, and Bei Yin Mei saw gains of 4.24%, 3.36%, and 3.25% respectively [1] - The assisted reproductive sector experienced a net outflow of 1.895 billion yuan, with 57 stocks facing net outflows, and 12 stocks seeing outflows exceeding 50 million yuan [1] Group 2 - The top net outflow stock was Hanyu Pharmaceutical, with a net outflow of 256 million yuan, followed by Guangsheng Tang, Anke Biological, and Zhongsheng Pharmaceutical with net outflows of 189 million yuan, 149 million yuan, and 129 million yuan respectively [2] - The stocks with the highest net inflows included Hc Pharma, Bei Yin Mei, and Puni Testing, with net inflows of 48.48 million yuan, 35.29 million yuan, and 24.35 million yuan respectively [1][4]

New Stock Issuance - The new stock issuance for Zhigao Machinery (证券代码: 920101) is priced at 17.41 CNY per share, effective from August 5, 2025[1] - China Heavy Industry (证券代码: 601989) has a cash option declaration period from August 13, 2025[1] - China Shipbuilding (证券代码: 600150) has a buyback request period from August 13 to August 15, 2025[1] Offer and Acquisition Periods - Shenkou Co., Ltd. (证券代码: 002633) has a tender offer period from July 29 to August 27, 2025[1] - ST Kelly (证券代码: 300326) has a tender offer period from July 17 to August 15, 2025[1] - Happiness Blue Ocean (证券代码: 300528) has a significant announcement on July 30, 2025[1] Market Volatility - There are reports of severe abnormal fluctuations for Tibet Tourism (证券代码: 600749) as of July 31, 2025[1] - ST Suwu (证券代码: 600200) also reported significant volatility on July 30, 2025[1] - The stock of ST YaTai (证券代码: 000691) is under observation for abnormal trading activities as of August 5, 2025[1]

Group 1: New Stock Offerings - Shenke Co., Ltd. (002633) has a tender offer period from July 29, 2025, to August 27, 2025[1] - ST Kelly (300326) has a tender offer period from July 17, 2025, to August 15, 2025[1] - ST Zitian (300280) has a tender offer period ending on July 21, 2025[1] Group 2: Market Alerts - Xizang Tourism (600749) reported severe abnormal fluctuations on July 31, 2025[1] - Tianlu Convertible Bonds (110060) announced significant market activity on July 30, 2025[1] - ST Suwu (600200) experienced unusual trading patterns on July 30, 2025[1] Group 3: Additional Announcements - Happiness Blue Ocean (300528) issued a notice on July 30, 2025, regarding market conditions[1] - Common Pharmaceutical (300966) provided updates on August 1, 2025, related to stock performance[1] - Dongjie Intelligent (300486) released a statement on August 1, 2025, concerning market volatility[1]

Group 1 - The stock of Hubei Gongtong Pharmaceutical Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 30% over three consecutive trading days from July 30 to August 1, 2025 [1] - The company's board of directors conducted a verification regarding the abnormal trading situation and confirmed that there are no undisclosed significant information or major matters under planning that could affect the stock price [1][1] - The board also stated that there are no undisclosed matters that should be disclosed according to the Shenzhen Stock Exchange's rules, and previous disclosures do not require correction or supplementation [1][1]